Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | TYRO3 |
Upstream (Parents) |
---|
(<<) HMGA2 → TYRO3 |
(<<) MRC1L1///MRC1 → TYRO3 |
(<<) FCGR2B → TYRO3 |
(<<) PLK1 → TYRO3 |
(<<) ABCC1 → TYRO3 |
(<<) MCOLN1 → TYRO3 |
Downstream (Children) |
---|
TYRO3 → MYH3 (>>) |
TYRO3 → HRC (>>) |
TYRO3 → CAV3 (>>) |
TYRO3 → ASPHD1 (>>) |
TYRO3 → SRY (>>) |
TYRO3 → IGF2AS (>>) |
TYRO3 → LAMA5 (>>) |
TYRO3 → RPL21P64///EEF1DP5 (>>) |
TYRO3 → KIAA0513 (>>) |
TYRO3 → TG (>>) |